dc.contributor.author |
Giannouli, S |
en |
dc.contributor.author |
Paterakis, G |
en |
dc.contributor.author |
Ziakas, PD |
en |
dc.contributor.author |
Anagnostou, D |
en |
dc.contributor.author |
Voulgarelis, M |
en |
dc.date.accessioned |
2014-03-01T11:45:53Z |
|
dc.date.available |
2014-03-01T11:45:53Z |
|
dc.date.issued |
2004 |
en |
dc.identifier.issn |
0390-6078 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/37678 |
|
dc.subject |
splenic marginal zone lymphoma |
en |
dc.subject |
CD5 |
en |
dc.subject.classification |
Hematology |
en |
dc.subject.other |
B-CELL LYMPHOMAS |
en |
dc.subject.other |
VILLOUS LYMPHOCYTES |
en |
dc.title |
Splenic marginal zone lymphomas with peripheral CD5 expression |
en |
heal.type |
other |
en |
heal.language |
English |
en |
heal.publicationDate |
2004 |
en |
heal.abstract |
We report 4 cases of splenic marginal zone lymphoma (SMZL) with peripheral CD5 positive, B-cell lymphocytosis. This unusual immunophenotypic discordance raises dilemmas in the diagnostic approach of these patients. In addition, this association may be related to a more aggressive clinical course, as 3 out of 4 of our patients died from progressive disease. |
en |
heal.publisher |
FERRATA STORTI FOUNDATION |
en |
heal.journalName |
HAEMATOLOGICA |
en |
dc.identifier.isi |
ISI:000188254000021 |
en |
dc.identifier.volume |
89 |
en |
dc.identifier.issue |
1 |
en |
dc.identifier.spage |
113 |
en |
dc.identifier.epage |
114 |
en |